NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/18/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization112.71 mln
Float14.65 mln
Earnings Date11/12/2026
Piotroski F-Score
1
/ 9
Very weak
1-Year Forecast
11.11
Transformational upside
Relative Strength
22
/ 100
Significantly lagging
Debt / Equity
0.01
Debt-free
ROE
-66.22
Deeply negative
ROA
-60.46
Deeply negative
Business Description
Aardvark Therapeutics is a San Diego-based drug development company founded in 2017. It works on creating oral medicines that trigger the body's natural processes to help treat conditions like obesity and diabetes.
